Academic collaborations with the pharmaceutical industry can help turn promising research discoveries into new therapies, technologies, and real-world patient benefit. But successful partnerships require the right partners, clear expectations, and mutual trust.

This seminar brings together representatives from Anocca, Bristol Myers Squibb (BMS), MSD, NEOGAP, Karolinska Institutet, and Karolinska University Hospital to share practical insights into how academia, healthcare, and industry can collaborate effectively.

The session will offer inspiration and concrete advice for researchers, clinicians, and company representatives who are interested in building meaningful partnerships. Speakers will discuss different types of collaboration, share their own experiences and challenges, and highlight key lessons learned.

The seminar is open for everyone. 

Date & time: May 20, 14.00–18.00

Location: Novum Forskningspark, Blickagången 6

Programme:

14:00 - 14:15 Welcome and Introduction: Life Science Cluster Flemingsberg and Cancer Research KI
14:15 - 14:30 Matthias Löhr, Professor of Gastroenterology & Hepatology at KI
14:30 - 14:45 Evren Alici, Principal Researcher, Docent at KI
14:45 - 15:00 Luke Pase, Chief Technology Officer at Anocca
15:00 - 15:15 Hans Grönlund, CSO and founder at NEOGAP
15:15 - 15:30 Adrian Levitsky, Nordic Medical Advisor, Oncology at BMS 
15:30 - 15:45 Stina Salomonsson, Executive Director Outcomes Research & Nina Zisko, Associate Director of Regional Outcomes Research at MSD
15:45 - 16:00 Conclusions
16:00 - 18:00 Wrap-up, Drinks & Networking. Unwind and connect with fellow researchers, industry representatives, and entrepreneurs over drinks and snacks.

Welcome!

About Cancer Research KI

Cancer Research KI is an overarching umbrella organisation of cancer research at Karolinska Institutet, that includes more than 410 research groups. The aim is to combine cancer research with clinical oncology by bringing together top level cancer scientists from different disciplines, with the goal to aid generating new scientific discoveries that can be rapidly translated into clinical practice for the benefit of patients and society.